Literature DB >> 30523754

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.

Harold J Burstein1, Christina Lacchetti2, Jennifer J Griggs3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30523754     DOI： 10.1200/JOP.18.00617

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  9 in total

1.  Extracting Multiple Worries From Breast Cancer Patient Blogs Using Multilabel Classification With the Natural Language Processing Model Bidirectional Encoder Representations From Transformers: Infodemiology Study of Blogs.

Authors:  Tomomi Watanabe; Shuntaro Yada; Eiji Aramaki; Hiroshi Yajima; Hayato Kizaki; Satoko Hori
Journal:  JMIR Cancer       Date:  2022-06-03

Review 2.  Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.

Authors:  Kate E Roberts; India T Adsett; Kirsty Rickett; Sophie M Conroy; Mark D Chatfield; Natasha E Woodward
Journal:  Cochrane Database Syst Rev       Date:  2022-01-10

Review 3.  Managing Common Estrogen Deprivation Side Effects in HR+ Breast Cancer: an Evidence-Based Review.

Authors:  Bethânia Soares Dos Santos; Cláudia Bordignon; Daniela Dornelles Rosa
Journal:  Curr Oncol Rep       Date:  2021-04-14       Impact factor: 5.075

4.  Application of a Biphasic Mathematical Model of Cancer Cell Drug Response for Formulating Potent and Synergistic Targeted Drug Combinations to Triple Negative Breast Cancer Cells.

Authors:  Jinyan Shen; Li Li; Niall G Howlett; Paul S Cohen; Gongqin Sun
Journal:  Cancers (Basel)       Date:  2020-04-27       Impact factor: 6.639

5.  Baduanjin's impact on quality of life and sleep quality in breast cancer survivors receiving aromatase inhibitor therapy: a randomized controlled trial.

Authors:  Jingwen Liao; Yanyu Chen; Li Cai; Kun Wang; Shenghui Wu; Lan Wu; Bixiao Song; Min Hu; Xiaohui Hou
Journal:  Front Oncol       Date:  2022-08-05       Impact factor: 5.738

6.  Development and Refinement of a Telehealth Intervention for Symptom Management, Distress, and Adherence to Adjuvant Endocrine Therapy after Breast Cancer.

Authors:  Jamie M Jacobs; Emily A Walsh; Chelsea S Rapoport; Michael H Antoni; Elyse R Park; Kathryn Post; Amy Comander; Jeffrey Peppercorn; Steven A Safren; Jennifer S Temel; Joseph A Greer
Journal:  J Clin Psychol Med Settings       Date:  2020-11-21

7.  Quality and reporting of clinical guidelines for breast cancer treatment: A systematic review.

Authors:  Marta Maes-Carballo; Luciano Mignini; Manuel Martín-Díaz; Aurora Bueno-Cavanillas; Khalid Saeed Khan
Journal:  Breast       Date:  2020-08-10       Impact factor: 4.380

Review 8.  Shared decision making in breast cancer treatment guidelines: Development of a quality assessment tool and a systematic review.

Authors:  Marta Maes-Carballo; Isabel Muñoz-Núñez; Manuel Martín-Díaz; Luciano Mignini; Aurora Bueno-Cavanillas; Khalid Saeed Khan
Journal:  Health Expect       Date:  2020-08-03       Impact factor: 3.377

9.  The Use and Concurrent Use of Side Effect Controlling Medications Among Women on Aromatase Inhibitors.

Authors:  Amy H Farkas; Aaron Winn; Liliana E Pezzin; Nicole Fergestrom; Prakash Laud; Joan M Neuner
Journal:  J Womens Health (Larchmt)       Date:  2020-10-26       Impact factor: 2.681
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.